Protective, restorative, and therapeutic properties of recombinant human IL-1 in rodent models

M. P. Castelli, P. L. Black, M. Schneider, R. Pennington, F. Abe, J. E. Talmadge

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Human rIL-1α and -1β are shown to increase significantly the CFU-culture activity in the spleen as well as at other sites after i.v. or i.p. administration. IL-1 can also significantly increase survival and can 'rescue' a number of animals if administered either before or after lethal doses of cyclophosphamide or γ-irradiation. The protective and reconstitutive activities of the rIL-1 are shown to correlate with increased CFU-culture frequency and total number, as well as increased cellularity in the bone marrow and peripheral blood, suggesting that this is one of their mechanisms of action. The sequence and timing of administration of human rIL-1 is critical for the protection or rescue of animals receiving DNA-damaging agents; maximal activity is achieved when IL-1 is given 20 h before insult or 48 h after alkylating agent administration. Minimal therapeutic activity is observed with IL-1 as a single agent for the treatment of metastatic disease compared with other biologic response modifiers including IFN-γ.

Original languageEnglish (US)
Pages (from-to)3830-3837
Number of pages8
JournalJournal of Immunology
Volume140
Issue number11
StatePublished - Jan 1 1988

Fingerprint

Interleukin-1
Rodentia
Alkylating Agents
Cyclophosphamide
Therapeutics
Spleen
Bone Marrow
Survival
DNA

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Castelli, M. P., Black, P. L., Schneider, M., Pennington, R., Abe, F., & Talmadge, J. E. (1988). Protective, restorative, and therapeutic properties of recombinant human IL-1 in rodent models. Journal of Immunology, 140(11), 3830-3837.

Protective, restorative, and therapeutic properties of recombinant human IL-1 in rodent models. / Castelli, M. P.; Black, P. L.; Schneider, M.; Pennington, R.; Abe, F.; Talmadge, J. E.

In: Journal of Immunology, Vol. 140, No. 11, 01.01.1988, p. 3830-3837.

Research output: Contribution to journalArticle

Castelli, MP, Black, PL, Schneider, M, Pennington, R, Abe, F & Talmadge, JE 1988, 'Protective, restorative, and therapeutic properties of recombinant human IL-1 in rodent models', Journal of Immunology, vol. 140, no. 11, pp. 3830-3837.
Castelli MP, Black PL, Schneider M, Pennington R, Abe F, Talmadge JE. Protective, restorative, and therapeutic properties of recombinant human IL-1 in rodent models. Journal of Immunology. 1988 Jan 1;140(11):3830-3837.
Castelli, M. P. ; Black, P. L. ; Schneider, M. ; Pennington, R. ; Abe, F. ; Talmadge, J. E. / Protective, restorative, and therapeutic properties of recombinant human IL-1 in rodent models. In: Journal of Immunology. 1988 ; Vol. 140, No. 11. pp. 3830-3837.
@article{a6a8c203489642ae88a98acab252e6e0,
title = "Protective, restorative, and therapeutic properties of recombinant human IL-1 in rodent models",
abstract = "Human rIL-1α and -1β are shown to increase significantly the CFU-culture activity in the spleen as well as at other sites after i.v. or i.p. administration. IL-1 can also significantly increase survival and can 'rescue' a number of animals if administered either before or after lethal doses of cyclophosphamide or γ-irradiation. The protective and reconstitutive activities of the rIL-1 are shown to correlate with increased CFU-culture frequency and total number, as well as increased cellularity in the bone marrow and peripheral blood, suggesting that this is one of their mechanisms of action. The sequence and timing of administration of human rIL-1 is critical for the protection or rescue of animals receiving DNA-damaging agents; maximal activity is achieved when IL-1 is given 20 h before insult or 48 h after alkylating agent administration. Minimal therapeutic activity is observed with IL-1 as a single agent for the treatment of metastatic disease compared with other biologic response modifiers including IFN-γ.",
author = "Castelli, {M. P.} and Black, {P. L.} and M. Schneider and R. Pennington and F. Abe and Talmadge, {J. E.}",
year = "1988",
month = "1",
day = "1",
language = "English (US)",
volume = "140",
pages = "3830--3837",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "11",

}

TY - JOUR

T1 - Protective, restorative, and therapeutic properties of recombinant human IL-1 in rodent models

AU - Castelli, M. P.

AU - Black, P. L.

AU - Schneider, M.

AU - Pennington, R.

AU - Abe, F.

AU - Talmadge, J. E.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Human rIL-1α and -1β are shown to increase significantly the CFU-culture activity in the spleen as well as at other sites after i.v. or i.p. administration. IL-1 can also significantly increase survival and can 'rescue' a number of animals if administered either before or after lethal doses of cyclophosphamide or γ-irradiation. The protective and reconstitutive activities of the rIL-1 are shown to correlate with increased CFU-culture frequency and total number, as well as increased cellularity in the bone marrow and peripheral blood, suggesting that this is one of their mechanisms of action. The sequence and timing of administration of human rIL-1 is critical for the protection or rescue of animals receiving DNA-damaging agents; maximal activity is achieved when IL-1 is given 20 h before insult or 48 h after alkylating agent administration. Minimal therapeutic activity is observed with IL-1 as a single agent for the treatment of metastatic disease compared with other biologic response modifiers including IFN-γ.

AB - Human rIL-1α and -1β are shown to increase significantly the CFU-culture activity in the spleen as well as at other sites after i.v. or i.p. administration. IL-1 can also significantly increase survival and can 'rescue' a number of animals if administered either before or after lethal doses of cyclophosphamide or γ-irradiation. The protective and reconstitutive activities of the rIL-1 are shown to correlate with increased CFU-culture frequency and total number, as well as increased cellularity in the bone marrow and peripheral blood, suggesting that this is one of their mechanisms of action. The sequence and timing of administration of human rIL-1 is critical for the protection or rescue of animals receiving DNA-damaging agents; maximal activity is achieved when IL-1 is given 20 h before insult or 48 h after alkylating agent administration. Minimal therapeutic activity is observed with IL-1 as a single agent for the treatment of metastatic disease compared with other biologic response modifiers including IFN-γ.

UR - http://www.scopus.com/inward/record.url?scp=0023905482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023905482&partnerID=8YFLogxK

M3 - Article

C2 - 3259600

AN - SCOPUS:0023905482

VL - 140

SP - 3830

EP - 3837

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 11

ER -